Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avista (AVA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Avista (AVA) over the last 17 years, with Q3 2025 value amounting to $26.0 million.

  • Avista's Change in Accured Expenses fell 1612.9% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 7294.1%. This contributed to the annual value of $13.0 million for FY2024, which is 1333.33% down from last year.
  • Per Avista's latest filing, its Change in Accured Expenses stood at $26.0 million for Q3 2025, which was down 1612.9% from -$44.0 million recorded in Q2 2025.
  • In the past 5 years, Avista's Change in Accured Expenses ranged from a high of $31.0 million in Q3 2024 and a low of -$44.0 million during Q2 2025
  • In the last 5 years, Avista's Change in Accured Expenses had a median value of $7.1 million in 2021 and averaged $3.5 million.
  • Per our database at Business Quant, Avista's Change in Accured Expenses crashed by 645540.54% in 2021 and then skyrocketed by 30672.55% in 2024.
  • Avista's Change in Accured Expenses (Quarter) stood at -$4.9 million in 2021, then tumbled by 476.93% to -$28.0 million in 2022, then skyrocketed by 141.32% to $11.6 million in 2023, then tumbled by 143.23% to -$5.0 million in 2024, then soared by 620.0% to $26.0 million in 2025.
  • Its Change in Accured Expenses stands at $26.0 million for Q3 2025, versus -$44.0 million for Q2 2025 and $31.0 million for Q1 2025.